Trials@Home Consortium (2024). Opportunities and challenges for decentralized clinical trial approaches: European health technology assessment perspective. Value in Health, 27(3), 294-300. https://doi.org/10.1016/j.jval.2023.11.006

Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S. J., Groenwold, R. H. H., & Gardarsdottir, H. (2023). Unintended impact of pharmacovigilance regulatory interventions: A systematic review. British Journal of Clinical Pharmacology, 89(12), 3491-3502. https://doi.org/10.1111/bcp.15874
https://dspace.library.uu.nl/bitstream/handle/1874/434300/Brit_J_Clinical_Pharma_-_2023_-_Lasys_-_Unintended_impact_of_pharmacovigilance_regulatory_interventions_A_systematic.pdf?sequence=1

Trials@Home Consortium (2023). Direct-to-Participant Investigational Medicinal Product Supply in Clinical Trials in Europe - Exploring the Experiences of Sponsors, Site Staff, and Couriers. British Journal of Clinical Pharmacology, 89(12), 3512-3522. https://doi.org/10.1111/bcp.15850
https://dspace.library.uu.nl/bitstream/handle/1874/434222/Brit_J_Clinical_Pharma_-_2023_-_Jong_-_Direct_to_participant_investigational_medicinal_product_supply_in_clinical_trials_in.pdf?sequence=1

Trials@Home Consortium (2023). Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus. Drug Discovery Today, 28(4), Article 103520. https://doi.org/10.1016/j.drudis.2023.103520

Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S., Groenwold, R. H. H., & Gardarsdottir, H. (2022). Unintended impact of medicines regulatory interventions: A systematic review focusing on data and methods. Pharmacoepidemiology and Drug Safety, 31, 223-224.

Trials@Home Consortium (2022). Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review. Drug Discovery Today, 27(10), 1-6. Article 103326. https://doi.org/10.1016/j.drudis.2022.07.011

Trials@Home Consortium (2022). Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov. BMJ Open, 12(8). https://doi.org/10.1136/bmjopen-2022-063236

Trials@Home Consortium (2022). Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective. Clinical Pharmacology and Therapeutics, 112(2), 344-352. https://doi.org/10.1002/cpt.2628

Lopes, L. C., Salas, M., Osorio-de-Castro, C. G. S., Leal, L. F., Doubova, S. V., Cañás, M., Dreser, A., Acosta, A., Baldoni, A. O., de Cássia Bergamaschi, C., Mota, D. M., Gómez-Galicia, D. L., Sepúlveda-Viveros, D., Delgado, E. N., da Costa Lima, E., Chandia, F. V., Ferre, F., Marin, G. H., Olmos, I., ... Elseviers, M. (2022). Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study. Pharmacoepidemiology and Drug Safety, 31(3), 343-352. https://doi.org/10.1002/pds.5404

Rodríguez-Bernal, C. L., Santa-Ana-Téllez, Y., García-Sempere, A., Hurtado, I., Peiró, S., & Sanfélix-Gimeno, G. (2021). Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population-based propensity-weighted cohort study. British Journal of Clinical Pharmacology, 87(2), 632-643. https://doi.org/10.1111/bcp.14430

Trials@Home Consortium (2021). COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union. Clinical Pharmacology and Therapeutics, 109(6), 1517-1527. https://doi.org/10.1002/cpt.2225

García-Sempere, A., Hurtado, I., Bejarano, D., Santa-Ana, Y., Rodríguez-Bernal, C., Peiró, S., & Sanfélix-Gimeno, G. (2020). Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes. Medical Care, 58(4), e23-e30. https://doi.org/10.1097/MLR.0000000000001253

García-Sempere, A., Rein, N. V. (Ed.), Hurtado, I., Bejarano-Quisoboni, D., Rodríguez-Bernal, C., Santa-Ana, Y., Peiró, S., & Sanfélix-Gimeno, G. (2019). Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study. PLoS One. https://doi.org/10.1371/journal.pone.0211681

Hurtado-Navarro, I., García-Sempere, A., Rodríguez-Bernal, C., Santa-Ana-Tellez, Y., Peiró, S., & Sanfélix-Gimeno, G. (2018). Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain. Frontiers in Pharmacology, 9, 1353. https://doi.org/10.3389/fphar.2018.01353

Gray, A. L., Santa-Ana-Tellez, Y., & Wirtz, V. J. (2016). Impact of the introduction of mandatory generic substitution in South Africa: private sector sales of generic and originator medicines for chronic diseases. Tropical medicine & international health. https://doi.org/10.1111/tmi.12785

Santa Ana Tellez, Y., Teeuwisse, A. K., Leufkens, H. G. M., & Wirtz, V. J. (2016). Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis. Health Policy and Planning, 31(9), 1291-1296. https://doi.org/10.1093/heapol/czw066
https://dspace.library.uu.nl/bitstream/handle/1874/346936/10.pdf?sequence=1

Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & Wirtz, V. J. (2015). Reply to "decrease in penicillin sales in Brazil after over-the-counter restrictions". Antimicrobial Agents and Chemotherapy, 59(9), 5864. https://doi.org/10.1128/AAC.01128-15

Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & Wirtz, V. J. (2015). Seasonal Variation in Penicillin Use in Mexico and Brazil: Analysis of the Impact of Over-the-Counter Restrictions. Antimicrobial Agents and Chemotherapy, 59(1), 105-10. https://doi.org/10.1128/AAC.03629-14

Santa-Ana-Tellez, Y. (2013). Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries. Tropical medicine & international health : TM & IH. https://doi.org/10.1111/tmi.12096

Galárraga, O., Wirtz, V. J., Santa-Ana-Tellez, Y., Korenromp, E. L., & Braitstein, P. (Ed.) (2013). Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay? PLoS One. https://doi.org/10.1371/journal.pone.0067565

Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Dreser, A., Leufkens, H. G. M., & Wirtz, V. J. (2013). Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS One, 8(10), e75550. https://doi.org/10.1371/journal.pone.0075550

Wirtz, V. J., Santa-Ana-Tellez, Y., Servan-Mori, E., & Avila-Burgos, L. (2012). Heterogeneous Effects of Health Insurance on Out-of-Pocket Expenditure on Medicines in Mexico. Value in Health. https://doi.org/10.1016/j.jval.2012.01.006

Wirtz, V. J., Santa-Ana-Tellez, Y., Trout, C. H., & Kaplan, W. A. (2012). Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America. Health Policy and Planning. https://doi.org/10.1093/heapol/czs011

Santa-Ana-Tellez, Y., DeMaria, L. M., & Galárraga, O. (2011). Costs of interventions for AIDS orphans and vulnerable children: Costs for AIDS-related OVC programs. Tropical medicine & international health. https://doi.org/10.1111/j.1365-3156.2011.02856.x

Galárraga, O., Wirtz, V. J., Figueroa-Lara, A., Santa-Ana-Tellez, Y., Coulibaly, I., Viisainen, K., Medina-Lara, A., & Korenromp, E. L. (2011). Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries. PharmacoEconomics. https://doi.org/10.2165/11586120-000000000-00000

González-Block, M. Á., Sauceda-Valenzuela, A. L., & Ana-Téllez, Y. S. (2010). Factores asociados a la demanda de servicios para la atención del parto en México. Salud Pública de México. https://doi.org/10.1590/s0036-36342010000500009

Sauceda-Valenzuela, A. L., Wirtz, V. J., Santa-Ana-Téllez, Y., & Kageyama-Escobar, M. D. L. L. (2010). Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico. BMC Health Services Research. https://doi.org/10.1186/1472-6963-10-178